Hirashima T - Search Results

1

[Prognostic significance of alterations in telomeric repeat length in patients with pathological stage I-II non-small cell lung cancer].

Hirashima T, Komiya T, Nitta T, Kobayashi M, Kawase I. Hirashima T, et al. Nihon Rinsho. 1998 May;56(5):1264-71. Nihon Rinsho. 1998. PMID: 9613135 Japanese.

2

Significance of serum neuron-specific enolase as a predictor of relapse of small cell lung cancer.

Nitta T, Fukuoka M, Masuda N, Kusunoki Y, Matsui K, Kudoh S, Hirashima T, Yana T, Ito K, Takada M. Nitta T, et al. Among authors: hirashima t. Jpn J Clin Oncol. 1995 Oct;25(5):179-83. Jpn J Clin Oncol. 1995. PMID: 7474404

3

Prognostic significance of serum p53 antibodies in squamous cell carcinoma of the lung.

Komiya T, Hirashima T, Takada M, Masuda N, Yasumitsu T, Nakagawa K, Hosono Y, Kikui M, Tsuji S, Fukuoka M, Kawase I. Komiya T, et al. Among authors: hirashima t. Anticancer Res. 1997 Sep-Oct;17(5B):3721-4. Anticancer Res. 1997. PMID: 9427768

4

Phase II trial of carboplatin plus oral etoposide for elderly patients with small-cell lung cancer.

Matsui K, Masuda N, Fukuoka M, Yana T, Hirashima T, Komiya T, Kobayashi M, Kawahara M, Atagi S, Ogawara M, Negoro S, Kudoh S, Furuse K. Matsui K, et al. Among authors: hirashima t. Br J Cancer. 1998 Jun;77(11):1961-5. doi: 10.1038/bjc.1998.325. Br J Cancer. 1998. PMID: 9667675 Free PMC article. Clinical Trial.

5

Combination of irinotecan and etoposide for treatment of refractory or relapsed small-cell lung cancer.

Masuda N, Matsui K, Negoro S, Takifuji N, Takeda K, Yana T, Kobayashi M, Hirashima T, Kusunoki Y, Ushijima S, Kawase I, Tada T, Sawaguchi H, Fukuoka M. Masuda N, et al. Among authors: hirashima t. J Clin Oncol. 1998 Oct;16(10):3329-34. doi: 10.1200/JCO.1998.16.10.3329. J Clin Oncol. 1998. PMID: 9779709

6

p21 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lung.

Komiya T, Hosono Y, Hirashima T, Masuda N, Yasumitsu T, Nakagawa K, Kikui M, Ohno A, Fukuoka M, Kawase I. Komiya T, et al. Among authors: hirashima t. Clin Cancer Res. 1997 Oct;3(10):1831-5. Clin Cancer Res. 1997. PMID: 9815570

7

Clinical significance of p53 in non-small-cell lung cancer.

Komiya T, Hirashima T, Kawase I. Komiya T, et al. Among authors: hirashima t. Oncol Rep. 1999 Jan-Feb;6(1):19-28. Oncol Rep. 1999. PMID: 9864395 Review.

8

Prognostic significance of CYFRA 21-1 in non-small cell lung cancer.

Hirashima T, Takada M, Komiya T, Nitta T, Masashi K, Masuda N, Matui K, Kikui M, Yasumitsu T, Kawase I. Hirashima T, et al. Anticancer Res. 1998 Nov-Dec;18(6B):4713-6. Anticancer Res. 1998. PMID: 9891546

9

GPI-anchored molecule-like protein (GML) expression in non-small cell lung cancer (NSCLC).

Komiya T, Hirashima T, Kikui M, Fukuoka M, Ohno A, Kawase I. Komiya T, et al. Among authors: hirashima t. Anticancer Res. 1999 Sep-Oct;19(5B):4315-9. Anticancer Res. 1999. PMID: 10628393

10

Prognostic significance of hTERT expression in non-small cell lung cancer.

Komiya T, Kawase I, Nitta T, Yasumitsu T, Kikui M, Fukuoka M, Nakagawa K, Hirashima T. Komiya T, et al. Among authors: hirashima t. Int J Oncol. 2000 Jun;16(6):1173-7. doi: 10.3892/ijo.16.6.1173. Int J Oncol. 2000. PMID: 10811992

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

392 results

Search Page

Filters